{
    "code": "51058193",
    "url": "https:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=51058193",
    "time": "2018-04-27 03:06:23",
    "許可證字號": "衛部藥製字第058193號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "有效日期": "108\/01\/23",
    "發證日期": "103\/01\/23",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHY05105819301",
    "中文品名": "特莫斯膠囊250毫克",
    "英文品名": "Tamos Capsules 250mg",
    "適應症": "新診斷的多形神經膠母細胞瘤，與放射治療同步進行，然後作為輔助性治療。給予標準治療後復發性或惡化之惡性神經膠質瘤，例如多形神經膠母細胞瘤或退行性星狀細胞瘤。",
    "劑型": "130膠囊劑",
    "包裝": "2-1000顆玻璃瓶裝 2-1000顆塑膠瓶裝",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "06須由醫師處方使用",
    "主成分略述": [
        "TEMOZOLOMIDE"
    ],
    "限制項目": "01國　產 24監視期滿學名藥",
    "申請商名稱": "0901301200  美時化學製藥股份有限公司",
    "主製造廠": {
        "主製造廠": "",
        "製造廠名稱": "0901314300  美時化學製藥股份有限公司南投廠",
        "製造廠廠址": "南投縣南投市新興里成功一路３０號",
        "製造廠公司地址": ""
    },
    "CCC號列": "",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "1004002000",
            "成分名稱": "TEMOZOLOMIDE",
            "含量描述": "",
            "含量": "250.0000000000",
            "單位": "MG"
        }
    ],
    "仿單外盒": [
        {
            "title": "51058372 058193 Temozolomide_仿單_new version_20180307-107-03-14.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=51058193&Seq=006&Type=9"
        },
        {
            "title": "010581930001_Tamos Cap. 250mg_仿單-104-12-22(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=51058193&Seq=005&Type=9"
        },
        {
            "title": "010581930003_Tamos Cap. 250mg_瓶裝外盒-104-12-22(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=51058193&Seq=010&Type=8"
        }
    ]
}